← Back to the page you were readingYou opened this term from another page.
IP · Patent strategyTask: Check a product

Patent thicket

Published by Patsnap Team Updated 4 sources
Definition

Patent thicket is a label used by generic companies for broad secondary patenting around a basic product, as recorded in the European Commission's 2009 Pharmaceutical Sector Inquiry1. The European Commission's 2009 inquiry notes that these terms are not defined in patent legislation1.

The FTC's 2003 report quoted Shapiro's description of overlapping intellectual property rights through which a company must navigate to commercialize technology2. A 2013 study commissioned by the UK IPO said the origins and especially the effects of patent thickets remained incompletely understood3.

AppliesThe European Commission's 2009 inquiry treats the label as industry terminology1.
Comes upThe FTC's 2003 report quotes Shapiro's description of overlapping IP rights2.
Used byThe European Commission's 2009 inquiry records generic companies' use of the label1.
Not to confuse withThe European Commission's 2009 inquiry says the label implies no negative patent-law assessment1.
01

The reports' terminology

The FTC's 2003 report attributes its description of a patent thicket to Shapiro in footnote 20 of the executive summary2.

The European Commission's 2009 inquiry says its industry terms are not intended to determine patent-law assessment, which instead uses statutory patentability criteria1.

02

Views recorded in the pharmaceutical inquiry

ViewpointAttribution in the report
Generic companiesThe European Commission's 2009 inquiry, paragraph 506, records generics calling broad secondary patenting around a basic product patent thickets1
Originator companies and associationsThe European Commission's 2009 inquiry, paragraph 502, records their objection that challenge outcomes do not substantially indicate the quality of patents in clusters because generic challengers select contentious, commercially interesting patents1
Terminology caveatThe European Commission's 2009 inquiry, paragraph 20, says the label does not imply a negative assessment under patent law1
03

Research limits and the US consultation

The 2013 study commissioned by the UK IPO states that its findings and opinions are the researchers' and do not necessarily represent the IPO or government3.

The 2013 study commissioned by the UK IPO expressly notes that much remains to be learned about origins and effects3.

The USPTO's 2022 notice at 87 FR 67019 sought comments on USPTO-FDA collaboration initiatives, including discussion of the FDA's concerns about practices referred to as patent thickets, evergreening, and product hopping4.

04

Questions people ask

Patsnap EurekaEureka IP

Check a product

FTO Search AI Agent

An AI agent that finds in-force patents that could read on your product, with a claim chart for each one.

Run FTO Search
Is patent thicket a statutory patent category?

No, the European Commission's 2009 inquiry places the term within industry terminology that is not defined in patent legislation1.

Does calling patents a thicket determine their validity?

No, the European Commission's 2009 terminology caveat says patentability depends on statutory criteria rather than these industry labels1.

Did the UK IPO study settle the effects of patent thickets?

No, the 2013 study commissioned by the UK IPO says much remains to be learned about their origins and especially their effects3.

05

How it connects

Next step

Go from the term to the task

Read how the method works, run it on your own product or idea, then try a free tool.

  • 01 / How-toHow to run a freedom-to-operate analysisScope, search, claim review and the report counsel will ask for.GuideRead
  • 02 / AI agentFTO Search AI AgentAn AI agent that finds in-force patents that could read on your product, with a claim chart for each one.Patsnap EurekaRun it
PublishedPatsnap Team
Updated 17 November 2026
Sources
  1. Pharmaceutical Sector Inquiry: Final Report. European Commission · report · 2009. Accessed 17 November 2026.
  2. To Promote Innovation: The Proper Balance of Competition and Patent Law and Policy. Federal Trade Commission · report · 2003. Accessed 17 November 2026.
  3. A Study of Patent Thickets. UK Intellectual Property Office · commissioned study · 2013. Accessed 17 November 2026.
  4. Joint USPTO-FDA Collaboration Initiatives; Notice of Public Listening Session and Request for Comments. USPTO · Federal Register notice · 2022. Accessed 17 November 2026.
Disclaimer

General information only. This page explains a term for general information and reference only. It is not legal, accounting, tax or other professional advice and must not be relied upon as such. It does not create an attorney-client or other professional relationship.

Sources and accuracy. Statements on this page are intended to be either general background or linked to a source listed under Sources. The explanations summarize and simplify those sources and leave out detail. Where this page differs from a cited source or from the current official text of a law or standard, rely on that source or text. To the extent permitted by law, this page is provided as is, without any warranty that it is complete, accurate or current, and Patsnap accepts no liability for loss arising from reliance on it. See also Patsnap’s website Disclaimer.

Rules vary and change. The law, standards and practice described here differ between jurisdictions and change through legislation, court decisions and revisions to official guidance and standards. This page was last checked against its sources on 17 November 2026 and may not reflect later changes. Check the current rules and official guidance in each jurisdiction that applies to you.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Third-party names, marks and links. Names of courts, government bodies, parties, people, companies, standards and products appear for identification only. Some of these names are trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap. Links to third-party sources are provided for reference, and Patsnap is not responsible for their content or availability.

Patsnap Eureka. Patsnap publishes this glossary and also offers Patsnap Eureka, a commercial product mentioned on this page. Those mentions describe what its tools are designed to do, not what they will find in a particular case. Their outputs are research aids and should be reviewed by a qualified professional before being relied on.

Corrections and requests. If you believe a statement on this page is inaccurate or out of date, use “Share feedback” at the bottom of this page and tell us which statement and why. If you are named on this page, or your concern is about legal rights or personal information, email legal@patsnap.com. We review reports and may correct or update the page.

FTO Search AI AgentRun FTO Search in Patsnap EurekaStart →

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.